Acutus Medical to Participate in Upcoming Investor Conferences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Acutus Medical, an arrhythmia management company (Nasdaq: AFIB), announces its participation in upcoming investor conferences. On May 4, 2021, the management team will attend the Truist Securities 7th Annual Life Sciences Summit. Additionally, on May 13, 2021, they will present at the Bank of America Merrill Lynch 2021 Global Healthcare Conference at 10:15 a.m. Eastern Time. The presentation will be available via a live audio webcast, with a replay accessible for 90 days afterward. Acutus focuses on innovative solutions for cardiac arrhythmias.
Details
News Market Reaction – AFIB
The recorded move for AFIB in the trading session of this news was +4.65%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CARLSBAD, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will participate at the following upcoming investor conferences:
- Attend investor meetings at the Truist Securities 7th Annual Life Sciences Summit on Tuesday, May 4, 2021.
- Present at the Bank of America Merrill Lynch 2021 Global Healthcare Conference on Thursday, May 13, 2021 at 10:15 a.m. Eastern Time. A live, audio-only webcast of the presentation may be accessed by visiting ir.acutusmedical.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 90 days following the presentation.
About Acutus Medical
Acutus Medical is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, Acutus has established a global sales presence delivering a broad portfolio of highly differentiated electrophysiology products that provide its customers with a complete solution for catheter-based treatment of cardiac arrhythmias. Founded in 2011, Acutus is based in Carlsbad, California.
Investor Contact:
Caroline Corner
Westwicke ICR
D: 415-202-5678
caroline.corner@westwicke.com
Holly Windler
M: 619-929-1275
media@acutusmedical.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.